Drug Profile
BIVN 401
Alternative Names: BIVN-401; Methylene blue - Oklahoma Medical Research; Methylthioninium chloride - Oklahoma Medical Research; Suvus; VirostatLatest Information Update: 31 Mar 2022
Price :
$50
*
At a glance
- Originator Oklahoma Medical Research Foundation
- Developer Bioenvision
- Class Antivirals; Phenothiazines; Small molecules
- Mechanism of Action Virus replication inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Hepatitis C
- Discontinued Influenza virus infections; West Nile virus infections
Most Recent Events
- 05 Dec 2008 No development reported - Preregistration for Hepatitis C in Egypt (PO)
- 23 Oct 2007 Bioenvision has been acquired by Genzyme Corporation
- 12 Sep 2007 Discontinued - Phase-II for Hepatitis C treatment in Europe (PO)